Top news of the week: 04.08.2020.
Biotechnology, Antibody, Initial public offering, Medicine, C-reactive protein, Preston Estep
Startups
Genscript chief, the majority shareholder of Legend, becomes China biotech’s new CEO https://t.co/QcD78SQ3pj https://t.co/7lB27ep9Yp
OpenGenscript chief, the majority shareholder of Legend, becomes China biotech’s new CEO
After its mega $424 million IPO this summer, blood cancer focused Legend Biotech is making a big change at the top.
The government's 'Shark Tank'-style coronavirus testing challenge awards $250 million to 7 companies https://t.co/5OdWkLrU7u by @katiedjennings
OpenThe Government’s ‘Shark Tank’-Style Coronavirus Testing Challenge Awards $250M To 7 Companies
The National Institutes of Health negotiated contracts with companies including Mammoth Biosciences and Ginkgo Bioworks to help scale up their Covid-19 testing technologies.
RT @matthewherper: Brigham president resigns from Moderna board after conflict of interest questions raised https://t.co/5YUMFazjmC
OpenBrigham president resigns from Moderna board after conflict of interest questions raised
Dr. Elizabeth Nabel's hospital is participating in the Cambridge biotech's trial of a COVID-19 vaccine. She recently sold stock in it worth nearly $6.5m.
Kymera Therapeutics, fresh off a $2B Sanofi biobucks pact, guns for an IPO https://t.co/LdXCBT7iEM https://t.co/MMMbb3mMbu
OpenKymera Therapeutics, fresh off a $2B Sanofi biobucks pact, guns for an IPO
Preclinical protein degradation biotech Kymera Therapeutics has a great year, nabbing a $102 million round for its march to the clinic, as well as a major tie up with French Big Pharma ...
The concept of citizen science is oxymoronic and sets a horrible example at a time when science and evidence based medicine are under attack. Fascinating reporting by @antonioregalado. https://t.co/TjDrgMs0yy
OpenSome scientists are taking a DIY coronavirus vaccine, and nobody knows if it’s legal or if it works
Preston Estep was alone in a borrowed laboratory, somewhere in Boston. No big company, no board meetings, no billion-dollar payout from Operation Warp Speed, the US government’s covid-19 ...
F-star set to land Nasdaq listing through Spring Bank merger https://t.co/UQMcNBbJti https://t.co/n9pHGLhW8g
OpenF-star set to land Nasdaq listing through Spring Bank merger
F-star Therapeutics is set to merge with Spring Bank Pharmaceuticals, giving it a Nasdaq listing to support the advance of its pipeline of bispecific antibodies. The merger comes months ...
RT @frankvinluan: Weeks after inking an R&D alliance w/ @Sanofi, @KymeraTx files papers for a $100M #IPO to fund clinical testing of its #proteindegradation drugs. Lead program expected to reach clinic in 2021 for skin diseases. Nasdaq listing planned, no ticker symbol yet https://t.co/TURXZRZDfn
OpenKymera Therapeutics Unveils IPO Pitch for Protein Degradation
Kymera Therapeutics has a pipeline of preclinical drug candidates that use an experimental approach to get rid of disease-causing proteins and it’s now
The explosion of #COVID19 research advances aims to put pandemic in the rearview: https://t.co/5UU4mRsxEq
OpenExplosion of COVID-19 research advances; aims to put pandemic in the rear view
Six months to the day that the World Health Organization (WHO) declared it a public health emergency, the SARS-CoV-2 virus, with its hideous red spikes, continues to taunt the world, ...